Drugs / Tetraspan®
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00797589 | Jan 2009 → Sep 2012 | heart valve disorder | University of Helsinki | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tetraspan | “6% HES solution (Tetraspan®)” NCT00797589 ↗ |
| Known as | HES | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00797589 ↗ |